Chemomab Therapeutics Ltd.

CMMB · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 12 employees
142
SEC Filings
$1.7
Close 2026-07-01
12
Employees

Business Summary

Overview Chemomab is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet needs. Based on the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and inflammation, Chemomab developed CM-101, a monoclonal antibody designed to bind and block CCL24 activity. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory di...

Latest Stock Quote

CMMB 2026-07-01 $1.7 O:$1.63 H:$1.753 L:$1.61 Vol:0.1M VWAP:$1.7145
origin leaf: null

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2023-03-202022-12-310001178913-23-001041EDGAR80K words
2022-03-302021-12-310001178913-22-001304EDGAR
2021-03-092020-12-310001104659-21-033822EDGAR
2020-03-172019-12-310001104659-20-034835EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2023-05-112023-03-310001178913-23-001807EDGAR10K words
2022-11-102022-09-300001178913-22-003931EDGAR
2022-08-122022-06-300001178913-22-003074EDGAR
2022-05-122022-03-310001178913-22-001919EDGAR
2021-11-122021-09-300001178913-21-003509EDGAR
2021-08-132021-06-300001178913-21-002696EDGAR
2021-05-132021-03-310001104659-21-065588EDGAR
2020-11-162020-09-300001104659-20-125523EDGAR
2020-08-142020-06-300001104659-20-095149EDGAR
2020-05-072020-03-310001104659-20-058143EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2023-06-160001178913-23-002225EDGAR1K words
2023-06-050001178913-23-002136EDGAR
2023-05-110001178913-23-001809EDGAR
2023-02-210001178913-23-000679EDGAR
2023-02-210001178913-23-000670EDGAR
2023-01-110001178913-23-000147EDGAR
2023-01-030001178913-23-000010EDGAR
2022-11-160001178913-22-004061EDGAR
2022-11-140001178913-22-004019EDGAR
2022-08-120001178913-22-003072EDGAR

142 total filings indexed. 118 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Company Identity

CIK0001534248
TickerCMMB
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedL3
Websitehttps://www.chemomab.com
Listed2021-03-17

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 66494116e44d0a001d5a97ad21d643cdc672ba01e2463e24bf33f4bc5cc8a149
parent: d1bd1ec98871afa1908a90060f11881a9623b0fcc4821b3d15d3dcf838dcb2cd
content hash: db36b07702d211239fa7931d29b1b2da04fdf4729974022475f0b211e6487cb5
signed: 2026-08-10T19:01:57.201Z
sources: 14 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up CMMB using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on CMMB, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/CMMB (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.